Cornerstone Planning Group
TEVA icon

Cornerstone Planning Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Cornerstone Planning Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-893
Closed -$26.9K – 1529
2026
Q2 		$26.9K Hold
893
– – ﹤0.01% 577
2026
Q1 		$32K Buy
893
+755
+547% +$24.3K ﹤0.01% 526
2025
Q4 		$4.58K Sell
138
-83
-38% -$2.04K ﹤0.01% 1011
2025
Q3 		$17.6K Buy
221
+165
+295% +$2.9K ﹤0.01% 624
2025
Q2 		$880 Buy
56
+38
+211% +$613 ﹤0.01% 1141
2025
Q1 		$257 Sell
18
-87
-83% -$1.55K ﹤0.01% 1439
2024
Q4 		$2.29K Buy
105
+86
+453% +$1.56K ﹤0.01% 762
2024
Q3 		$350 Buy
19
+18
+1,800% +$315 ﹤0.01% 1161
2024
Q2 		$17 Hold
1
– – ﹤0.01% 1235
2024
Q1 		$14 Hold
1
– – ﹤0.01% 1082
2023
Q4 		$10 Hold
1
– – ﹤0.01% 949
2023
Q3 		$10 Buy
+1
New +$9 ﹤0.01% 1192

Other funds holding TEVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Bourgeon Capital Management
Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
CA
Continental Advisors Park City, Utah $233M AUM 14.5% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Burford Brothers
Burford Brothers Dallas, Texas $275M AUM 18.76% 1-Year Est. Return

Cornerstone Planning Group's TEVA Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 893 shares — an estimated $26.9K sold.

Cornerstone Planning Group first reported a position in TEVA in Q3 2023 and held it in 12 quarters. The position peaked at $32K in Q1 2026. 101 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 893 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $26.9K.
  • Cornerstone Planning Group first reported a position in Teva Pharmaceutical Industries Limited in Q3 2023 and held it in 12 quarters.
  • Cornerstone Planning Group's Teva Pharmaceutical Industries Limited position peaked at $32K in Q1 2026.
  • 101 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.